These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 9500630)

  • 21. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
    McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
    J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
    Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for the development of coronary artery disease of a grafted heart as detected very early after orthotopic heart transplantation.
    Kocík M; Málek I; Janek B; Zelízko M; Pirk J
    Transpl Int; 2007 Aug; 20(8):666-74. PubMed ID: 17521382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary artery disease in pediatric cardiac transplant recipients receiving triple-drug immunosuppression.
    Braunlin EA; Hunter DW; Canter CE; Gutierrez FR; Ring WS; Olivari MT; Titus JL; Spray TL; Bolman RM
    Circulation; 1991 Nov; 84(5 Suppl):III303-9. PubMed ID: 1657452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased early mortality in women undergoing cardiac transplantation.
    Wechsler ME; Giardina EG; Sciacca RR; Rose EA; Barr ML
    Circulation; 1995 Feb; 91(4):1029-35. PubMed ID: 7850938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relationship among donor-recipient HLA mismatches, rejection, and death from coronary artery disease in cardiac transplant recipients.
    Kerman RH; Kimball P; Scheinen S; Radovancevic B; Van Buren CT; Kahan BD; Frazier OH
    Transplantation; 1994 Mar; 57(6):884-8. PubMed ID: 8154036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease?
    Radovancevic B; Golino A; Vrtovec B; Thomas CD; Radovancevic R; Odegaard P; van Rossem CC; Gaemers SJ; Vaughn WK; Smart FW; Frazier OH
    J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Routine surveillance endomyocardial biopsy continues to detect significant rejection late after heart transplantation.
    Gradek WQ; D'Amico C; Smith AL; Vega D; Book WM
    J Heart Lung Transplant; 2001 May; 20(5):497-502. PubMed ID: 11343975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantation.
    Baan CC; Holweg CT; Niesters HG; van Gelder T; Mol WM; Zondervan PE; Mochtar B; Balk AH; Weimar W
    J Heart Lung Transplant; 1998 Apr; 17(4):363-73. PubMed ID: 9588581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is biopsy-proven cellular rejection an important clinical consideration in heart transplantation?
    Kirklin JK
    Curr Opin Cardiol; 2005 Mar; 20(2):127-31. PubMed ID: 15711199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
    Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
    J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac allograft vasculopathy and graft failure in pediatric heart transplant recipients after rejection with severe hemodynamic compromise.
    Kleinmahon JA; Gralla J; Kirk R; Auerbach SR; Henderson HT; Wallis GA; Ramakrishnan K; Singh RK; Caldwell RL; Savage AJ; Everitt MD
    J Heart Lung Transplant; 2019 Mar; 38(3):277-284. PubMed ID: 30638837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characteristics of long-term renal transplant survivors.
    Peddi VR; Whiting J; Weiskittel PD; Alexander JW; First MR
    Am J Kidney Dis; 1998 Jul; 32(1):101-6. PubMed ID: 9669430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. Cardiac Transplant Research Database Group.
    Kubo SH; Naftel DC; Mills RM; O'Donnell J; Rodeheffer RJ; Cintron GB; Kenzora JL; Bourge RC; Kirklin JK
    J Heart Lung Transplant; 1995; 14(3):409-18. PubMed ID: 7654724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early versus late acute antibody-mediated rejection in renal transplant recipients.
    Dörje C; Midtvedt K; Holdaas H; Naper C; Strøm EH; Øyen O; Leivestad T; Aronsen T; Jenssen T; Flaa-Johnsen L; Lindahl JP; Hartmann A; Reisæter AV
    Transplantation; 2013 Jul; 96(1):79-84. PubMed ID: 23632391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
    Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
    J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation.
    Labarrere CA; Nelson DR; Cox CJ; Pitts D; Kirlin P; Halbrook H
    JAMA; 2000 Jul; 284(4):457-64. PubMed ID: 10904509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic allograft dysfunction in kidney transplant recipients: long-term single-center study.
    Boratyńska M; Wakulenko A; Klinger M; Szyber P
    Transplant Proc; 2014 Oct; 46(8):2673-7. PubMed ID: 25380892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.